- Home
- AVPT vs CPRX Comparison
AVPT vs CPRX Comparison
Compare AVPT & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVPT
- CPRX
- Stock Information
- Founded
- AVPT 2001
- CPRX 2002
- Country
- AVPT United States
- CPRX United States
- Employees
- AVPT N/A
- CPRX N/A
- Industry
- AVPT Computer Software: Prepackaged Software
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- AVPT Technology
- CPRX Health Care
- Exchange
- AVPT Nasdaq
- CPRX Nasdaq
- Market Cap
- AVPT 3.0B
- CPRX 2.9B
- IPO Year
- AVPT N/A
- CPRX 2006
- Fundamental
- Price
- AVPT $18.85
- CPRX $23.37
- Analyst Decision
- AVPT Buy
- CPRX Strong Buy
- Analyst Count
- AVPT 5
- CPRX 7
- Target Price
- AVPT $17.00
- CPRX $32.29
- AVG Volume (30 Days)
- AVPT 877.0K
- CPRX 975.9K
- Earning Date
- AVPT 05-08-2025
- CPRX 05-07-2025
- Dividend Yield
- AVPT N/A
- CPRX N/A
- EPS Growth
- AVPT N/A
- CPRX 178.13
- EPS
- AVPT N/A
- CPRX 1.57
- Revenue
- AVPT $349,012,000.00
- CPRX $534,645,999.00
- Revenue This Year
- AVPT $18.61
- CPRX $15.59
- Revenue Next Year
- AVPT $18.52
- CPRX $8.90
- P/E Ratio
- AVPT N/A
- CPRX $14.90
- Revenue Growth
- AVPT 21.70
- CPRX 29.97
- 52 Week Low
- AVPT $8.06
- CPRX $14.47
- 52 Week High
- AVPT $19.90
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- AVPT 77.79
- CPRX 50.33
- Support Level
- AVPT $16.56
- CPRX $20.80
- Resistance Level
- AVPT $17.30
- CPRX $25.01
- Average True Range (ATR)
- AVPT 0.49
- CPRX 0.83
- MACD
- AVPT 0.29
- CPRX -0.06
- Stochastic Oscillator
- AVPT 84.40
- CPRX 61.05
About AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).